A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.
about
Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies.Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 TrimerOne protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.Emerging amyloid disease-modifying drugs for Alzheimer's disease.
P2860
A noninflammatory immune response in aged DNA Aβ42-immunized mice supports its safety for possible use as immunotherapy in AD patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
A noninflammatory immune respo ...... immunotherapy in AD patients.
@en
A noninflammatory immune respo ...... immunotherapy in AD patients.
@nl
type
label
A noninflammatory immune respo ...... immunotherapy in AD patients.
@en
A noninflammatory immune respo ...... immunotherapy in AD patients.
@nl
prefLabel
A noninflammatory immune respo ...... immunotherapy in AD patients.
@en
A noninflammatory immune respo ...... immunotherapy in AD patients.
@nl
P2860
P1476
A noninflammatory immune respo ...... immunotherapy in AD patients.
@en
P2093
Roger N Rosenberg
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2014.12.011
P577
2014-12-12T00:00:00Z